Diagnostic Imaging Equipment Servicing – Market Insights – United States

Following the recovery from the impact of the COVID-19 pandemic, the US diagnostic imaging equipment servicing market will see marginal growth through 2032. The market growth will primarily be hindered by the increasing adoption of advanced diagnostic imaging systems across various modalities. This will lead to a reduction in the market demand for technologically inferior diagnostic imaging systems, ultimately resulting in their gradual phase-out from the market. Additionally, hospital budget constraints—supported by hospital consolidations and influence of GPOs—will constrict the market growth in the US.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for diagnostic imaging equipment servicing market in the US from 2019 through 2032.

Diagnostic imaging equipment system market will grow marginally over the forecast period.

Which segments will see the strongest growth through 2032?

What factors will drive growth in the overall market?

What factors are hampering growth of the overall market?

Product innovations are supporting growing sales of advanced diagnostic imaging systems, thereby spurring servicing contract sales.

How are the product innovations in the diagnostic imaging systems impacting the servicing market in US?

Which particular segments of the market will experience the highest number of innovations?

The US diagnostic imaging equipment servicing market is dominated by large, multimodality OEMs.

What factors help the OEMs to maintain competitive edge in the servicing market?

How are these OEMs strengthening their position in the market?

FDA has released regulations on third-party servicing of diagnostic imaging systems.

What are some regulations released by FDA with respect to third-party servicing?

How will the new FDA regulations impact the third-party servicing business?

Table of contents

Diagnostic Imaging Equipment Servicing - Market Insights - United States

Contact sales Login to access report

Back to all Medtech Insights reports